TAVI stands for Transcatheter Aortic Valve Implantation. It is also referred to as TAVR (Transcatheter Aortic Valve Replacement).
The procedure is for individuals diagnosed with severe symptomatic aortic stenosis and are at intermediate or greater risk for open heart surgery.
The TAVI/TAVR procedure allows a new valve to be inserted within the diseased aortic valve. During the procedure, the new valve pushes the leaflets of the current diseased valve aside. The frame uses the leaflets of the diseased valve to secure it in place.
TAVI/TAVR is a less invasive procedure. It uses a catheter to replace the heart valve instead of opening up the chest of the patient and completely removing the diseased valve. It can be performed in multiple ways.
TAVI (Transcatheter Aortic Valve Implantation) procedure is for individuals who have been diagnosed with severe symptomatic aortic stenosis and are at intermediate or greater risk for open heart surgery.
There are several factors that determine whether or not you are at intermediate or greater risk for open heart surgery, and therefore, a possible candidate for TAVI/TAVR.
5 major factors include:
Remember, each patient is unique. Talk to our Heart Team to assess you better.
The Heart Team will conduct various tests or assessments, such as a chest X-ray, echo, angiogram, and others to review your condition.
It is important that you inform your Heart Team about any medication you may be taking. Your doctor will advise you about regulating your intake prior to the procedure.
The average procedure time varies from 1 to 2 hours.
The Heart Team determines immediate after-care plan
After the TAVI/TAVR procedure, the patient may be taken to the ICU, or may be taken directly to the hospital floor.
Specific discharge advise
The Heart Team gives specific instructions to help with recovery, which may include a special diet, exercise, and medicine. It is important to carefully follow the doctorbs directions, especially if blood-thinning drugs are prescribed. The Heart Team will schedule follow-up visits with you.
You will be expected to attend regular check-ups
Regular check-ups with your doctor are very important. Call or see your doctor whenever you have questions or concerns about your health, especially if you experience any unusual problems such as bleeding, pain, other discomfort, or changes in your overall health.
Quicker recovery time
TAVI/TAVR helps your heart work better. It helps shorten the recovery time there by helping the patient get back to living life.
Less invasive procedure
The procedure is less invasive as compared to surgical valve replacement.
Shorter hospitalisation period
The average duration of hospitalisation usually ranges between 2-4 days as compared to open-heart procedure.
Quality of life improvement
The procedure has seen patient health improvements within 30 days, including: the ability to take care of themselves and ability to participate in everyday activities.
Over the last decade, multiple studies and clinical trials have proven the use of TAVI/TAVR in high risk patients and demonstrated encouraging clinical outcomes. This then lead to comparing the use of the TAVI/TAVR technology in intermediate risk patients and compare it with the standard of care i.e Surgical Aortic Valve Replacement.
TAVI/TAVR in intermediate-risk patients was superior at 1 year to surgical valve replacement, with lower rates of death, strokes, and the composite endpoint of death, strokes, and moderate to severe aortic regurgitation combined.
Moreover, other infrequent but nonetheless important procedure-related complications, including coronary occlusion, annulus rupture, and device embolisation were also decreased after TAVI/TAVR at 30 days.
Compared to surgery, TAVI/TAVR also yielded significantly lower rates of acute kidney injury, severe bleeding events and new onset atrial fibrillation.
TAVI/TAVR patients spent less time in the hospital overall bthe average time in the ICU was about two days with TAVI/TAVR versus four days with surgery, and the average hospitalization for TAVI/TAVR was six days compared to nine days with surgery.
TAVI/TAVR also appeared to improve the aortic valve areas more than surgery, meaning that the quality of the valvebs performance was better as measured by echocardiography during follow-up points through two years
The role of the Heart team and the proper selection of the patients have contributed to excellent clinical outcomes of TAVI/TAVR. The improvement in device technology is not only making the adoption of the technology easier but also improving the short term as well long term clinical outcomes superior
TAVI/TAVR with the new generation valves demonstrates good clinical outcomes in patients with severe aortic stenosis who are at intermediate risk of surgical mortality.
Mr. Nirmal Sadhuka
022 25763595 / 25763298